Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
13:29:20 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 0.0499 USD | 0.00% |
|
-0.20% | -10.73% |
| Market Cap | 20.97M 18.72M 17.27M 15.69M 29.43M 1.99B 29.89M 208M 81.95M 1.04B 78.72M 77.03M 3.3B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 23.7M 21.15M 19.52M 17.73M 33.26M 2.24B 33.77M 235M 92.61M 1.18B 88.96M 87.05M 3.73B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 week | -0.20% | ||
| Current month | -12.61% | ||
| 1 month | -3.67% | ||
| 3 months | -13.79% | ||
| 6 months | -7.08% | ||
| Current year | -10.73% |
| 1 week | 0.05 |  | 0.05 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 2024-04-15 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 2012-05-14 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 2019-03-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 2017-04-02 | |
John Lacey
BRD | Director/Board Member | 78 | 2018-04-26 |
Edward Pershing
CHM | Chairman | 73 | 2018-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/10/26 | Exercice | Chief Executive Officer | -22,609 | 0.0054% | ||
| 10/3/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 9/18/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.20% | -29.46% | -34.34% | 20.97M | |
| -4.10% | -8.54% | +40.05% | +66.99% | 63.29B | |
| -0.41% | +3.27% | +10.46% | +72.82% | 54.89B | |
| +0.74% | +4.04% | +12.18% | +88.71% | 53.28B | |
| +0.61% | +2.69% | +27.75% | +50.97% | 45.81B | |
| -1.08% | +2.19% | +21.92% | +131.38% | 43.46B | |
| -3.39% | -0.83% | +254.27% | +571.04% | 40.23B | |
| -1.67% | +6.70% | +14.42% | +56.67% | 33.45B | |
| -0.53% | -6.60% | +26.82% | -2.45% | 23.7B | |
| +1.30% | +4.94% | +38.23% | +28.59% | 23.76B | |
| Average | -0.85% | +0.95% | +41.66% | +103.04% | 38.19B | |
| Weighted average by Cap. | -1.14% | +0.89% | +47.75% | +121.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.51 0.46 0.87 58.46 0.88 6.12 2.41 30.63 2.32 2.27 97.02 | 0.34 0.3 0.28 0.25 0.47 31.84 0.48 3.33 1.31 16.68 1.26 1.23 52.84 |
| Net income | -4.76M -4.25M -3.92M -3.56M -6.68M -451M -6.79M -47.24M -18.61M -236M -17.88M -17.49M -749M | -5.43M -4.85M -4.47M -4.06M -7.62M -514M -7.74M -53.88M -21.22M -270M -20.39M -19.95M -854M |
| Net Debt | 2.88M 2.57M 2.37M 2.15M 4.04M 273M 4.1M 28.54M 11.24M 143M 10.8M 10.57M 452M | 2.73M 2.43M 2.25M 2.04M 3.83M 258M 3.89M 27.06M 10.66M 135M 10.24M 10.02M 429M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | US$0.0499 | 0.00% | 5,211 |
| 26-10-21 | US$0.0499 | 0.00% | 20,100 |
| 26-10-20 | US$0.0499 | +2.04% | 2,100 |
| 26-10-19 | US$0.0489 | +0.39% | 51,200 |
| 26-10-16 | US$0.0487 | -2.58% | 8,028 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
